Edwards and Medtronic who currently control over 80% of this market NOW face the real possibility of shortly confronting a competitor with,
i) A TAVR device with far superior tissue and
ii) A far superior delivery mechanism
How will it play out from here?
So exciting.
- Forums
- ASX - By Stock
- ADAPT TAVR -Just Better
AVR
anteris technologies global corp.
Add to My Watchlist
5.16%
!
$5.91

Edwards and Medtronic who currently control over 80% of this...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.91 |
Change
0.290(5.16%) |
Mkt cap ! $91.59M |
Open | High | Low | Value | Volume |
$5.79 | $6.19 | $5.79 | $17.15K | 2.906K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38 | $5.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.10 | 170 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 38 | 5.900 |
1 | 1000 | 5.850 |
1 | 500 | 5.600 |
1 | 3045 | 5.510 |
3 | 4281 | 5.500 |
Price($) | Vol. | No. |
---|---|---|
6.300 | 100 | 1 |
6.400 | 450 | 2 |
6.550 | 1092 | 1 |
6.650 | 100 | 1 |
7.100 | 2000 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online